claim
Harmala alkaloids act as monoamine oxidase inhibitors (MAOIs) and influence serotonin signaling similarly to selective serotonin reuptake inhibitors (SSRIs), allowing for dynamic regulation of BDNF levels.

Authors

Sources

Referenced by nodes (3)